发明名称 |
Sulphated hyaluronic acid for treating degenerative osteoarthritis |
摘要 |
This invention relates to oral and intra-articular formulations based on sulphated hyaluronic acid which are effective in the treatment of degenerative osteoarthritis. |
申请公布号 |
US8765714(B2) |
申请公布日期 |
2014.07.01 |
申请号 |
US201213410227 |
申请日期 |
2012.03.01 |
申请人 |
Fidia Farmaceutici S.p.A. |
发明人 |
Callegaro Lanfranco;Renier Davide |
分类号 |
A61K31/727;A01N43/04;A61K31/715 |
主分类号 |
A61K31/727 |
代理机构 |
Birch, Stewart, Kolasch & Birch, LLP |
代理人 |
Birch, Stewart, Kolasch & Birch, LLP |
主权项 |
1. A method for treating cartilage damage caused by degenerative osteoarthritis presenting without plasma infiltrates of cartilage comprising orally administering to a patient in need thereof an effective degenerative osteoarthritis treatment amount of a sulphated hyaluronic acid (HAS), wherein the hyaluronic acid used to prepare said HAS has a molecular weight between 100,000 and 230,000 D, and wherein said HAS has a degree of sulphation between 0.5 and 3.5, and where said administration is effective to increase within a joint exhibiting said cartilage damage the amount of the material that constitutes the scaffolding of the cartilage matrix. |
地址 |
Abano Terme IT |